Request a Quote

Cyprotex Highlights - November 2020

ADME PK

Cyprotex recently hosted two webinar series in collaboration with colleagues across the industry; Novartis, Genentech, ApconiX, University of Liverpool and Takeda. These series were popular events and we are now pleased to offer them to watch on demand.

A Focus on Drug Transporters

New Approaches in Toxicology

Webinars

Our latest publication, co-authored with our colleagues at the EU-ToxRisk consortium, is now available to read: ‘Comparing in vitro human liver models to in vivo human liver using RNA-Seq’, published in the Archives of Toxicology.

The paper covers the work performed to analyse several in vitro liver cell models and compare them to healthy human liver tissue using RNA-sequencing technology. Click on the link below to read more in our blog:

Read the blog

Read the paper

Single strand RNA

Read the latest news from parent company, Evotec:

  • Evotec & Bristol Myers Squibb achieve milestone in neurodegeneration collaboration
  • Mubadala Investment Company & Novo Holdings A/S announce investment in Evotec SE
  • Topas Therapeutics raises € 22 million in Series B financing & appoints Klaus Martin, Ph.D. as new CEO
  • Just - Evotec Biologics receives grant for antibody development for the prevention of COVID-19
  • Eternygen announces the first closing of its Series A2 funding round lead by investor Evotec
  • Introducing the Dorothy Crowfoot Hodgkin Campus: Evotec expands Oxfordshire site into a fully-integrated R&D centre
  • Evotec SE reports results & corporate update for the first nine months of 2020
  • Evotec & STORM Therapeutics leverage INDiGO platform to progress first-in-class clinical oncology candidate
  • Evotec presents progress made in accelerating its co-owned pipeline at Capital Markets Day
  • Evotec announces new drug discovery & development partnership with Rappta Therapeutics focused on innovative oncology target

Read the press releases

Webinars
Contact us

News categories

Archives

Close
Contact us to discuss your ADME Tox issues or request a quote

Telephone:
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683

or fill out the form below:

Close
Close

Download file

Close